Mounjaro Cost in the UK 2026: NHS, Private, and Japan Trip Alternative

1. The UK GLP-1 landscape in 2026

The UK weight-loss medication market has changed dramatically since Wegovy (semaglutide) launched here in 2023 and Mounjaro (tirzepatide) followed in 2024. Two years on, the picture in mid-2026 looks like this:

• NHS availability: Both Wegovy and Mounjaro are approved by NICE for adults with obesity, but only through specialist Tier 3 or Tier 4 weight management services. Access is heavily rationed and waiting lists are long.
• Private high-street: Boots Online Doctor, Superdrug Online Doctor, and LloydsDirect (LloydsPharmacy Online Doctor) dominate the mass private market with transparent pricing and Care Quality Commission-registered clinicians.
• Digital-first clinics: A wave of online-only brands — Voy (formerly Numan Weight), Numan, Manual, Second Nature, Juniper (via partnership), Habitual, and CheqUp — compete on packaging: bundled coaching, app-based tracking, and dose escalation support.
• Grey market and imports: A significant minority of UK patients source medication through personal travel or offshore pharmacies, often for cost reasons but sometimes to bypass NHS or private waiting lists.

The consistent theme: legitimate access to Mounjaro exists, but it is expensive and often slow. Almost every route requires a monthly commitment of at least £150, and higher doses can push total annual cost above £4,500.

2. NHS access: Wegovy, Mounjaro, and the waiting-list reality

On paper, the NHS covers tirzepatide (Mounjaro) and semaglutide (Wegovy) for weight management. In practice, access is one of the tightest bottlenecks in NHS specialist services in 2026.

Eligibility criteria (typical)

NICE and NHS England guidance for tirzepatide in weight management generally requires:

• BMI ≥35 kg/m² (or ≥32.5 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family backgrounds)
• At least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease
• Treatment within a specialist weight management service (Tier 3 or Tier 4), which requires GP referral
• Willingness to engage with lifestyle support alongside medication

Wegovy criteria are similar. Some regions apply stricter thresholds (e.g. BMI ≥40) simply because demand exceeds capacity.

The waiting-list reality

Multiple integrated care boards (ICBs) have publicly acknowledged that specialist weight management service waiting lists exceed 12-24 months in 2026. Some ICBs have paused accepting new referrals entirely. NHS England has phased Mounjaro rollout over several years, meaning even eligible patients may not receive treatment for years after referral.

The consequence is that for most UK patients — especially those below the BMI 40 threshold or without a diagnosed comorbidity — the NHS route is effectively unavailable in a timely way. This is the primary reason the private market has boomed.

3. Private UK pricing: Boots, Superdrug, Voy, and the rest

The private market splits into two broad tiers: high-street pharmacy brands (Boots, Superdrug, LloydsDirect) with transparent pricing and physical pharmacy backup, and digital-first clinics (Voy, Numan, Manual, Second Nature, Habitual) that emphasise packaging, coaching, and app experience.

Approximate 2026 monthly pricing for Mounjaro across major UK providers:

Wegovy (semaglutide) at the same providers typically runs a little higher — roughly £190-280/month for lower doses and £280-380/month for maintenance doses of 1.7mg and 2.4mg. This partly reflects Novo Nordisk’s pricing and partly the tighter global semaglutide supply situation.

What’s included — and what to check

• Initial consultation: Usually free with high-street pharmacies (Boots, Superdrug, LloydsDirect). Digital brands sometimes bundle a £25-50 assessment into the first month or charge for it separately.
• Delivery: Almost always free and next-day with tracked, refrigerated dispatch. Some clinics charge extra for Saturday delivery.
• Follow-up and dose escalation: Included by most, but check whether nurse or clinician calls beyond the standard cadence are chargeable.
• Coaching and behavioural support: The main differentiator. Second Nature, Habitual, and Voy invest heavily in app-based coaching. Boots and Superdrug offer more limited digital support.
• Auto-renewal: Most digital brands default to a monthly subscription. Read cancellation windows carefully — some require 7-14 days’ notice before the next dispatch.

4. The Japan option: pricing and logistics

Japan operates a national pharmaceutical pricing system where the Ministry of Health, Labour and Welfare (MHLW) sets official list prices for prescription medications. Tirzepatide (Mounjaro) sold in Japan is manufactured by the same Eli Lilly supply chain but retails at a fraction of UK, US, or EU prices — even at private (self-paid) clinics, since the underlying drug cost is anchored to that regulated price.

For a UK tourist visiting Japan, typical private-clinic Mounjaro pricing in 2026 looks like this:

A UK patient staying at 2.5mg for a full month typically pays around £125 — roughly 30-40% of the UK private price. For a 5mg maintenance dose, Japan pricing is roughly 55-70% of UK pricing. The savings compound at higher doses.

Getting the medication and getting home

• Consultation: Most Tokyo clinics serving international patients offer English-language online consultation before you arrive. This means the medication can be ready for collection or hotel delivery on day one.
• Payment: Credit card is standard at private clinics catering to foreigners. Cash is also accepted; larger amounts should be pre-arranged.
• Storage during travel: Mounjaro pens are stable at room temperature (≤30°C) for 21-30 days depending on the batch. For longer supplies, insulated travel bags are recommended.
• Documentation: You’ll receive a prescription and pharmacy dispensing record in Japanese and (from clinics serving foreigners) an English translation. Keep both for the UK border.

5. Total-cost breakeven scenarios

Local price is only part of the calculation. For a UK patient considering a Japan trip, you also need to factor in flights, accommodation, meals, and the time cost of travelling. Three realistic scenarios:

6. MHRA and HMRC personal import rules

UK residents returning from abroad with prescription medication for personal use are governed by MHRA (Medicines and Healthcare products Regulatory Agency) and HMRC guidance. The core principles:

• Personal use only: Medication must be for you or an immediate family member, not for resale or third-party supply.
• Reasonable quantity: Guidance suggests up to a 3-month supply is typically accepted without additional formalities for a licensed prescription medicine. Larger quantities may require a letter from your prescriber.
• Prescription documentation: Carry the prescribing document (Japanese and English translation ideally) and, where possible, the pharmacy dispensing record.
• Original packaging: Keep the medication in its manufacturer packaging with clear labelling.
• Controlled drugs: GLP-1 receptor agonists like tirzepatide are prescription-only in the UK but are not classified as controlled drugs, so the strict Home Office import licence rules that apply to opioids and stimulants do not apply here.

In practice, UK Border Force officers have discretion. A traveller declaring 3 pens of Mounjaro in original packaging, with a clear prescription letter, is very unlikely to face any issue. A traveller with 20 unlabelled pens and no documentation is likely to face questioning and possible seizure.

7. Alternative options and things to avoid

Compounded GLP-1 is not legal in the UK

Unlike the United States — where compounding pharmacies can produce tirzepatide preparations during official FDA shortages — the UK has no legal pathway for compounded semaglutide or tirzepatide. The MHRA has repeatedly warned against unlicensed weight-loss injections and taken enforcement action against sellers marketing to UK consumers. Any website advertising ‘compounded tirzepatide’ or ‘research-grade’ peptides for weight loss and shipping to UK addresses is operating outside the law, and the products are not quality-controlled.

Boots and Superdrug private pharmacies

For UK patients who want the safest, most convenient option without a trip, high-street online doctor services from Boots and Superdrug remain the default recommendation. Both offer:

• Clinician-led assessment via online questionnaire and (where needed) video call
• Standardised eligibility criteria (BMI ≥30 typically, or ≥27 with comorbidity)
• Refrigerated next-day delivery
• Dose escalation support and side-effect management
• Established complaints and safeguarding processes

Online-only digital clinics

Voy, Numan, Manual, Second Nature, Habitual, and CheqUp bundle clinician oversight with app-based coaching, community support, and sometimes personalised meal or exercise plans. Their price premium over Boots/Superdrug reflects that packaging. Whether the extra £20-40/month is worth it depends on how much you value structured behavioural support.

Sourcing from the EU

Since Brexit, importing medication from EU pharmacies into the UK is legally and logistically more complicated than pre-2020. EU online pharmacies generally will not ship prescription-only medicines to UK addresses. Travelling to Ireland or continental Europe for personal-supply purchase is possible but pricing in most EU markets is similar to or higher than UK private prices, so the economics rarely justify the trip.

What to avoid

• Grey-market Turkish or Indian imports shipped by post: legally risky, quality uncontrolled, and increasingly flagged at UK customs.
• Social-media ‘peptide’ sellers: universally unregulated, often selling unlicensed or mislabelled product.
• Sharing prescriptions: sharing GLP-1 medications with friends or family is illegal in the UK and clinically unsafe (individual dosing matters).

8. Which path fits your situation

Choose NHS if:

• You meet the BMI and comorbidity thresholds (BMI ≥35 with a comorbidity is typical)
• You can accept a 12-24 month wait for a specialist weight management service
• You value integrated NHS multidisciplinary support alongside medication

Choose UK private (Boots, Superdrug, Voy, etc.) if:

• You want to start within days or weeks
• You’re comfortable with £180-300/month ongoing cost
• You prefer a domestic clinician relationship with UK-based follow-up
• You’re on a shorter course (3-6 months) where travel doesn’t pay off

Consider a Japan trip if:

• You’re planning a 6+ month course and already thinking about Asia travel
• You want to combine treatment start with a genuine holiday
• You value avoiding UK auto-renewal subscription models
• You’re already going to Japan for work or family reasons
• You want the cost anchor of a regulated pricing system rather than a UK subscription that may escalate at higher doses

9. FAQ